ABOUT US
OUR HISTORYWe're Just Getting Started
We've hit some significant milestones in the beginning of our journey. And we're just getting started.
Our Team
Decades of experience dedicated to heart health excellence
Founder and CEOMichael D. Franklin
- Medical device innovator since 2005
- Experienced in design, development, program management and commercialization
A recognized authority in structural heart interventions, Michael has spent over two decades in both the R&D lab and the cath lab, pushing boundaries and challenging the status quo. His insight into what clinicians need – and what patients deserve – fuels Corvention’s mission to deliver the tools that elevate outcomes and streamline care.
Co-founder and COO/CFOFrank A. Hettmann
- IPO (EBR) and M&A (Avenu acquired by Medtronic) experience
- 30-year veteran successful in commercial launch and growth phase cycles
With a background in technology and life science innovation and strategy, Frank brings the vision and executional discipline that turns bold ideas into functional realities. Under his leadership, Corvention bridges technical excellence with market readiness, ensuring that game-changing products like KardiaPSI reach the hands of clinicians quickly and effectively.
VP of EngineeringRyan Smith
- Medical device innovator since 2015
- Leading technically-diverse product development programs to commercialization
Ryan brings over a decade of technical and leadership experience in the medical device industry, with a proven track record of delivering innovative technologies from concept through commercialization within cardiac, general surgery and OB/GYN sectors. Having held engineering leadership roles at a variety of health care enterprises, Ryan has extensive experience navigating FDA regulatory processes, clinical trials and market launch.
VP of Clinical & Medical AffairsAlex J. Froimovich, M.D.
- Dynamic executive with 20+ years of experience in medical devices
- Medical Affairs, Clinical Affairs and Marketing in TAVR, DES, DBS, and coronary physiology
Alex brings with him a long track record of meaningful innovation, having worked on some of the biggest blockbuster products in Interventional Cardiology like the first drug-eluting stent, the most popular transcatheter heart valve and the leading angio-based coronary physiology system. Alex excels at partnering with clinicians to bring technical marvels to the bedside.
PARTNERSStrategic Partners in the Pursuit of Excellence
Corvention is proud to collaborate with B. Braun Interventional Systems for distribution service throughout the United States.
Corvention is proud to collaborate with B. Braun Interventional Systems to ensure our cutting-edge structural heart technologies are available to clinicians and patients across the United States. Together, we are committed to delivering reliability when it matters most.
